Sam Altman, Mark Zuckerberg, and Jeff Bezos are trying to recreate what capitalism destroyed. The key difference is ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

In this role, Dr. Miao will lead the Nona AI team to advance the Company's A (3) (Antibody engineering × AI × Automation) strategy and further transform Nona into an AI-driven drug discovery company.

According to DataM Intelligence, the Global Cleanroom Technologies Market Size reached an estimated US$6.53 billion in 2024 ...

The importance of minority-interest remeasurement has expanded as joint venture and platform-licensing models become more common in biotech. For investors, such metrics provide an improved lens for ...

CPRIT award exceeds $7 million, with Diakonos selected as one of only nine awardees from a pool of 164 applicants Funding will support advancing DOC1021 into a Phase 1/2 clinical trial for patients ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The results, published Nov. 19 in The New England Journal of Medicine, suggest that ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...